News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ALPMY
Recent news which mentions ALPMY
< Previous
1
2
Next >
Merck, Pfizer-Backed Therapy Improves Outcomes For Cisplatin-Ineligible Bladder Cancer Patients
August 12, 2025
Tickers
ALPMF
ALPMY
MRK
NEWS
Tags
General
Top Stories
Health Care
From
Benzinga
Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study
July 10, 2025
Tickers
ALPMF
ALPMY
NEWS
NVS
Tags
Market News
NVS
News
From
Benzinga
JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovre
March 18, 2025
Tickers
ALPMF
ALPMY
APLS
NEWS
Tags
Analyst Ratings
ALPMF
Biotech
From
Benzinga
Pfizer/Astellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49% Reduction In Death Risk Vs. Chemo
February 11, 2025
Tickers
ALPMF
ALPMY
NEWS
PFE
Tags
ALPMF
ALPMY
Benzinga
From
Benzinga
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise
January 03, 2025
Tickers
ALPMF
ALPMY
ELEV
Tags
Initiation
Health Care
Analyst Ratings
From
Benzinga
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
December 31, 2024
Tickers
ALPMF
ALPMY
NEWS
PFE
Tags
Stories That Matter
Trading Ideas
PFE
From
Benzinga
1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street Analyst
October 29, 2024
Tickers
ALPMY
APLS
Tags
Recent Press Releases
ALPMY
Market News
From
Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
October 16, 2024
Tickers
ALPMF
ALPMY
APLS
NEWS
Tags
Initiation
News
Health Care
From
Benzinga
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
August 05, 2024
Tickers
ALPMF
ALPMY
AZN
MRK
Tags
Movers
why it's moving
Earnings
From
Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
Tickers
ABBV
ALPMY
BIIB
BMED
Tags
VHT
BIIB
RETA
From
Benzinga
White House asserts authority to break patents of certain high-cost drugs
December 07, 2023
Tickers
ALPMY
PFE
Tags
PFE
ALPMY
From
MarketWatch
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
October 05, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
Benzinga
ALPMY
Biotech
From
Benzinga
Here Are the 3 George Soros Stocks Most Likely to Turn $200,000 Into $1 Million Over the Next 20 Years
September 24, 2023
Tickers
ALPMY
AMZN
GOOG
GOOGL
Tags
GOOGL
Recent Press Releases
ALPMY
From
Motley Fool
Why Is Seagen Stock Trading Higher Today?
September 22, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
News
SGEN
Health Care
From
Benzinga
What's Going On With Neurology Focused Taysha Gene Therapies Stock Today?
September 20, 2023
Tickers
ALPMF
ALPMY
TSHA
Tags
Briefs
Movers
why it's moving
From
Benzinga
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
July 07, 2023
Tickers
ALPMY
BLU
FHLC
FXH
Tags
ISEE
ALPMY
Markets
From
Benzinga
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
June 08, 2023
Tickers
ALPMF
ALPMY
Tags
ALPMF
gene therapy
General
From
Benzinga
Why Shares of Annexon Are Plummeting Thursday
May 25, 2023
Tickers
ALPMY
ANNX
APLS
ISEE
Tags
ALPMY
Market News
ANNX
From
Motley Fool
Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today's Top Stories
May 15, 2023
Tickers
AAPL
ALPMF
ALPMY
BTI
Tags
GOOGL
Health Care
M&A
From
Benzinga
Astellas' Menopause Drug Sores FDA Approval, After Regulatory Setback
May 15, 2023
Tickers
ALPMF
ALPMY
Tags
ALPMF
General
FDA
From
Benzinga
Foreign businesses in China fear they’re being targeted in a ‘campaign’ of government crackdowns. It’s probably not that simple.
May 05, 2023
Tickers
ALPMY
MU
Tags
MU
ALPMY
JP:4503
From
MarketWatch
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
May 01, 2023
Tickers
ALPMY
APLS
ISEE
TGTX
Tags
ISEE
TGTX
Recent Press Releases
From
Motley Fool
Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
May 01, 2023
Tickers
ALPMF
ALPMY
PFE
Tags
Health Care
PFE
Large Cap
From
Benzinga
First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories
May 01, 2023
Tickers
ADDYY
ALPMY
BLMN
BNTX
Tags
REVRQ
Legal
SPY
From
Benzinga
Nasdaq, S&P 500 Futures On Edge Over First Republic Failure, Tech Earnings: Analyst Pins Hopes On Fed's Next Move
May 01, 2023
Tickers
ALPMY
CHKP
FRC
GPN
Tags
Futures
Penny Stocks
NIO
From
Benzinga
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'
May 01, 2023
Tickers
ALPMF
ALPMY
ISEE
Tags
Market News
News
Health Care
From
Benzinga
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
April 04, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
ALPMY
Benzinga
Biotech
From
Benzinga
Japanese Government Urges China To Release Astellas Pharma's Employee
March 27, 2023
Tickers
ALPMF
ALPMY
Tags
Legal
Market News
Health Care
From
Benzinga
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
March 17, 2023
Tickers
ALPMF
ALPMY
PFE
Tags
Biotech
Briefs
ALPMY
From
Benzinga
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
March 13, 2023
Tickers
ABBV
ALPMY
BMY
JNJ
Tags
Regulations
General
NVO
From
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.